SLIT2 has been shown to be a negative regulatory component of the DCC–netrin pathway 33, and normal expression of SLIT2 has been shown to repress growth and metastasis of squamous cell carcinomas and fibrosarcomas 23. Here, DCC is linked to fibrosarcoma.